+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Tyrosine Kinase Market 2020-2026

  • ID: 5148077
  • Report
  • July 2020
  • Region: Global
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
Global Tyrosine Kinase Market Size, Share & Trends Analysis Report by Type (BCR-ABL Tyrosine Kinase Inhibitor, Epidermal Growth Factor Receptor (EGFR), Vascular Endothelial Growth Factor Receptor (VEGFR), Anaplastic Lymphoma Kinase (ALK) and Others) by Application (Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer, Other) Forecast Period (2020-2026).

The tyrosine kinase market is anticipated to showcase a considerable growth rate during the forecast period. The growing demand for novel therapies for cancer treatment across the globe is a key factor to drive the growth of the global t market. However, the high cost of drug development is anticipated to be a key factor that may restrain the growth of the market across the globe.

The tyrosine kinase market is segmented on the basis of type and application. Based on the type, the tyrosine kinase market is segmented into BCR-ABL Tyrosine Kinase Inhibitor, Epidermal Growth Factor Receptor (EGFR), Vascular Endothelial Growth Factor Receptor (VEGFR), Anaplastic Lymphoma Kinase (ALK) and Others. Based on the application, the market is segmented into Chronic Myeloid Leukemia (CML), lung cancer, breast cancer, renal cell cancer, and others. Chronic Myeloid Leukemia (CML) is anticipated to witness significant growth based on application.

Geographically, the market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America is anticipated to hold a considerable market share in the market due to the high awareness of the drugs for the treatment of cancer in the region. Asia-Pacific is the fastest-growing region in the tyrosine kinase market. The increasing prevalence of cancer in the emerging economies of Asia-Pacific is a key factor contributing to the growth of the market in the region.

AstraZeneca PLC, GlaxoSmithKline PLC, Novartis International AG, Pfizer Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eisai Co., Ltd., Eurofarma Laboratórios S/A, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson and Johnson, and so on are the key companies operating in the tyrosine kinase market across the globe. The major players of the market are making hefty investments in the R&D of new drugs. The continuous efforts of the market players in the development of new drugs are driving the growth of the global market.

Research Methodology:

The market study of the global tyrosine kinase market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Global Tyrosine Kinase Market Research And Analysis By Type
2. Global Tyrosine Kinase Market Research And Analysis By Application

The Report Covers:
  • Comprehensive research methodology of the global tyrosine kinase market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global tyrosine kinase market.
  • Insights about market determinants which are stimulating the global tyrosine kinase market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Pfizer, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Novartis AG
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. F. Hoffmann La Roche Ltd.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. AstraZeneca PLC
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Bristol-Myers Squibb Company
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities

5. Market Segmentation
5.1. Global Tyrosine Kinase Market by Type
5.1.1. BCR-ABL Tyrosine Kinase Inhibitor
5.1.2. Epidermal Growth Factor Receptor (EGFR)
5.1.3. Vascular Endothelial Growth Factor Receptor (VEGFR)
5.1.4. Anaplastic Lymphoma Kinase (ALK)
5.1.5. Others
5.2. Global Tyrosine Kinase Market by Application
5.2.1. Chronic Myeloid Leukemia (CML)
5.2.2. Lung Cancer
5.2.3. Breast Cancer
5.2.4. Renal Cell Cancer
5.2.5. Other

6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. ARIAD Pharmaceuticals, Inc.
7.2. AstraZeneca PLC
7.3. Bayer AG
7.4. Boehringer Ingelheim International GmbH
7.5. Bristol-Myers Squibb Company
7.6. Eisai Co., Ltd.
7.7. Eurofarma Laboratórios S/A
7.8. F. Hoffmann-La Roche Ltd.
7.9. GlaxoSmithKline plc
7.10. Johnson and Johnson
7.11. Merck & Co., Inc.
7.12. Novartis AG
7.13. Pfizer Inc.
7.14. Puma Biotechnology
7.15. Sanofi S.A.
7.16. Wyeth, LLC
Note: Product cover images may vary from those shown
3 of 3
  • ARIAD Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • Eurofarma Laboratórios S/A
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Puma Biotechnology
  • Sanofi S.A.
  • Wyeth, LLC
Note: Product cover images may vary from those shown
Adroll
adroll